Profile of Local Interleukin Expression in a Cohort of Ocular Cicatricial Pemphigoid Patients

被引:16
作者
Suelves, Ana M. [1 ,2 ]
Zhao, Tong Z. [1 ,2 ]
Siddique, Sana S. [1 ,2 ]
Foster, C. Stephen [1 ,2 ,3 ]
机构
[1] Massachusetts Eye Res & Surg Inst, Cambridge, MA USA
[2] Ocular Immunol & Uveitis Fdn, Cambridge, MA USA
[3] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA
关键词
INTRAVENOUS IMMUNOGLOBULIN THERAPY; NECROSIS-FACTOR-ALPHA; TERM-FOLLOW-UP; CONJUNCTIVAL FIBROBLASTS; EXTRACELLULAR DOMAINS; AUTOANTIBODIES; PATHOGENESIS; COMPONENTS; EPITOPES; IGA;
D O I
10.1167/iovs.11-9322
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. We investigated the expression of IL-1, IL-6, IL-12, IL-13, and IL-17 in the conjunctiva of patients with ocular cicatricial pemphigoid (OCP), also labeled as ocular mucous membrane pemphigoid (MMP). METHODS. A retrospective case-control study was done on 5 biopsy-proven OCP subjects and 6 healthy volunteers. Conjunctival specimens were obtained, and the local expression of IL-1, IL-6, IL-12, IL-13, and IL-17 was studied by immunohistochemistry. Clinical and therapeutic features were collected during follow-up. RESULTS. No remarkable IL-1, IL-6, IL-12, IL-13, or IL-17 expression was observed in normal conjunctival specimens. All OCP samples had remarkable amounts of IL-12 and IL-17 expression especially in the epithelium and stroma; there also was stromal overexpression of IL-6. The mean follow-up after the biopsy was 13 months (range 9-15 months). CONCLUSIONS. Our results demonstrated, for the first time to our knowledge, a local overexpression of IL-6, IL-12, and IL-17 in conjunctiva of OCP compared to controls. (Invest Ophthalmol Vis Sci. 2012;53:8112-8117) DOI: 10.1167/iovs.11-9322
引用
收藏
页码:8112 / 8117
页数:6
相关论文
共 40 条
[1]   ASSOCIATION OF DQW7 (DQB1-STAR-0301) WITH OCULAR CICATRICIAL PEMPHIGOID [J].
AHMED, AR ;
FOSTER, S ;
ZALTAS, M ;
NOTANI, G ;
AWDEH, Z ;
ALPER, CA ;
YUNIS, EJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11579-11582
[2]   Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment [J].
Ahmed, M ;
Zein, G ;
Khawaja, F ;
Foster, CS .
PROGRESS IN RETINAL AND EYE RESEARCH, 2004, 23 (06) :579-592
[3]  
BEDELL A J, 1964, Trans Am Ophthalmol Soc, V62, P109
[4]  
BERNAUER W, 1993, OPHTHALMOLOGY, V100, P339
[5]  
BETTELHE.H, 1972, KLIN MONATSBL AUGENH, V160, P65
[6]   The autoantibodies to α6β4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human β4 [J].
Bhol, KC ;
Dans, MJ ;
Simmons, RK ;
Foster, CS ;
Giancotti, FG ;
Ahmed, AR .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2824-2829
[7]   Rapid effector function of circulating NC16A-specific T cells in individuals with mucous membrane pemphigoid [J].
Black, APB ;
Seneviratne, SL ;
Jones, L ;
King, AS ;
Winsey, S ;
Arsecularatne, G ;
Wojnarowska, F ;
Ogg, GS .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (06) :1160-1164
[8]  
Bruch-Gerharz D, 2007, EUR J DERMATOL, V17, P191
[9]   Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid [J].
Chan, LS ;
Hammerberg, C ;
Cooper, KD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (02) :129-132
[10]   The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators [J].
Chan, LS ;
Ahmed, AR ;
Anhalt, GJ ;
Bernauer, W ;
Cooper, KD ;
Elder, MJ ;
Fine, JD ;
Foster, S ;
Ghohestani, R ;
Hashimoto, T ;
Hoang-Xuan, T ;
Kirtschig, G ;
Korman, NJ ;
Lightman, S ;
Lozado-Nur, F ;
Marinkovich, MP ;
Mondino, BJ ;
Prost-Squarcioni, C ;
Rogers, RS ;
Setterfield, JF ;
West, DP ;
Wojnarowska, F ;
Woodley, DT ;
Yancey, KB ;
Zillikens, D ;
Zone, JJ .
ARCHIVES OF DERMATOLOGY, 2002, 138 (03) :370-379